Cite
HARVARD Citation
Fei, N. et al. (2021). SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Clinical and translational science. 14 (5), pp. 1822-1829. [Online].